News | August 03, 2025
Johnson & Johnson submits additional data to FDA on psoriatic arthritis
The submission is supported by results from the Phase 3b APEX study
The submission is supported by results from the Phase 3b APEX study
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Revenue increased 11.4 per cent to Rs. 8,545 crore
Upgrades 2025 full-year CDMO sales and margin outlook
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
